- Statements regarding the inclusion/exclusion of issues should be clearly supported by scientific evidence, and specifically outline the relevance of the suggested material to the guidelines.
- If you have identified any gaps or errors in the content please suggest suitable text for inclusion.
- Attach any supporting references or newly published evidence to be considered by the author group for inclusion to your comment.
How to post a public comment
- Create a user account and/or log in with your details
- To post a comment, click the blue 'Make a new comment' link below
- Fill in the empty boxes
- Warning: You need to fill out the subject line and box!
- Attach supporting references and any new papers to go with your comment and to be considered by the author group for inclusion by clicking on "Attach academic evidence".
- Press 'save page' to post your comment!
|Thread title||Replies||Last modified|
|Intrathecal adminstration of chemotherapy - error prevention||0||15:25, 2 June 2017|
Consider the following reference: Gilbar PJ. Intrathecal chemotherapy: Potential for medication error. Cancer Nursing 2014; 37(4): 299-309 This detailed review covers errors associated with the administration of intrathecal chemotherapy; both overdose errors and those due to the inadvertent intrathecal administration of drugs intended for the parenteral route. Table 3 details recommendations for preventing both types of errors.
Consider adding the statement, "Vincristine and other vinca alkaloids should be prepared for administration ONLY in a small-volume intravenous bag." Eliminating the syringe as a method for administration of these drugs is a guarantied way of preventing fatalities.